134 related articles for article (PubMed ID: 2624608)
1. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
2. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison].
Petru E; Berger MR; Zeller WJ; Kaufmann M
Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
Petru E; Berger MR; Zeller WJ; Kaufmann M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cytosolic sexual steroid receptors in autochthonous methylnitrosourea-induced rat mammary carcinoma following application of 2-chloroethylnitrosocarbamoyl-L-alanine linked to oestradiol or dihydrotestosterone.
Corr R; Berger MR; Betsch B; Floride JA; Brix HP; Schmähl D
Br J Cancer; 1990 Jul; 62(1):42-7. PubMed ID: 2390481
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapeutic characterization of new nitrosourea compounds].
Zeller WJ; Berger MR; Eisenbrand G; Petru E
Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-linked 2-chloroethylnitrosoureas: anticancer efficacy in MNU-induced rat mammary carcinoma, uterine activity in mice and receptor interactions.
Berger MR; Floride J; Schmähl D; Schreiber J; Eisenbrand G
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1179-91. PubMed ID: 3816911
[TBL] [Abstract][Full Text] [Related]
7. An oestradiol-linked nitrosourea and site-directed chemotherapy in mammary carcinoma.
Betsch B; Berger MR; Spiegelhalder B; Schmähl D; Eisenbrand G
Eur J Cancer; 1990; 26(8):895-8. PubMed ID: 2145934
[TBL] [Abstract][Full Text] [Related]
8. New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities?
Betsch B; Berger MR; Spiegelhalder B; Eisenbrand G; Schmähl D
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):105-11. PubMed ID: 2920758
[TBL] [Abstract][Full Text] [Related]
9. A new comprehensive technique of catheterisation, blood sampling, sample preparation and sample analysis by means of high-pressure liquid chromatography for pharmacokinetic studies with estradiol-linked nitrosoureas and their metabolites.
Betsch B; Berger MR; Spiegelhalder B
Arzneimittelforschung; 1990 Sep; 40(9):1022-5. PubMed ID: 2080936
[TBL] [Abstract][Full Text] [Related]
10. Contribution to the mechanism of Stilbostat action.
Görlich M; Heise E
Neoplasma; 1976; 23(4):363-9. PubMed ID: 1004653
[TBL] [Abstract][Full Text] [Related]
11. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
von Angerer E; Birnböck H; Knebel N
Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
[TBL] [Abstract][Full Text] [Related]
12. Development of more selective anti-cancer nitrosoureas.
Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
[TBL] [Abstract][Full Text] [Related]
13. Effect of castration and 17 beta-estradiol pulse on cell proliferation in the uterus and the MXT mouse mammary tumor.
Paridaens RJ; Danguy AJ; Leclercq G; Kiss R; Heuson JC
J Natl Cancer Inst; 1985 Jun; 74(6):1239-46. PubMed ID: 3858596
[TBL] [Abstract][Full Text] [Related]
14. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
[TBL] [Abstract][Full Text] [Related]
16. Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.
Devleeschouwer N; Leclercq G; Danguy A; Atassi G
Cancer Chemother Pharmacol; 1982; 8(3):315-6. PubMed ID: 7127663
[No Abstract] [Full Text] [Related]
17. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the anti-tumor effect of the E2 carrier drug and its mechanism].
Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):823-30. PubMed ID: 3598276
[TBL] [Abstract][Full Text] [Related]
19. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM
Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
Cantrell JE; Green D; Schein PS
Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]